Annual SGA
$50.40 M
+$6.45 M+14.67%
December 31, 2023
Summary
- As of February 6, 2025, ITOS annual SGA is $50.40 million, with the most recent change of +$6.45 million (+14.67%) on December 31, 2023.
- During the last 3 years, ITOS annual SGA has risen by +$35.06 million (+228.53%).
- ITOS annual SGA is now at all-time high.
Performance
ITOS SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$12.11 M
-$345.00 K-2.77%
September 30, 2024
Summary
- As of February 6, 2025, ITOS quarterly SGA is $12.11 million, with the most recent change of -$345.00 thousand (-2.77%) on September 30, 2024.
- Over the past year, ITOS quarterly SGA has dropped by -$257.00 thousand (-2.08%).
- ITOS quarterly SGA is now -19.79% below its all-time high of $15.10 million, reached on June 30, 2021.
Performance
ITOS Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
$324.27 M
-$121.25 M-27.22%
September 30, 2024
Summary
- As of February 6, 2025, ITOS TTM SGA is $324.27 million, with the most recent change of -$121.25 million (-27.22%) on September 30, 2024.
- Over the past year, ITOS TTM SGA has increased by +$273.90 million (+543.74%).
- ITOS TTM SGA is now -63.63% below its all-time high of $891.65 million.
Performance
ITOS TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
ITOS Selling, General & Administrative Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +14.7% | -2.1% | +543.7% |
3 y3 years | +228.5% | +38.3% | +785.1% |
5 y5 years | +1068.7% | +348.8% | +3569.5% |
ITOS Selling, General & Administrative Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +24.4% | -9.8% | +26.2% | -63.6% | +409.0% |
5 y | 5-year | at high | +470.3% | -19.8% | +432.2% | -63.6% | +197.0% |
alltime | all time | at high | +1068.7% | -19.8% | +584.7% | -63.6% | +197.0% |
ITeos Therapeutics Selling, General & Administrative Expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $12.11 M(-2.8%) | $49.64 M(-1.1%) |
Jun 2024 | - | $12.46 M(-1.9%) | $50.17 M(-1.9%) |
Mar 2024 | - | $12.70 M(+2.7%) | $51.15 M(+1.5%) |
Dec 2023 | $50.40 M(+14.7%) | $12.37 M(-2.2%) | $50.37 M(+2.6%) |
Sep 2023 | - | $12.64 M(-5.9%) | $49.10 M(+4.0%) |
Jun 2023 | - | $13.44 M(+12.6%) | $47.22 M(+4.3%) |
Mar 2023 | - | $11.93 M(+7.4%) | $45.26 M(+3.0%) |
Dec 2022 | $43.95 M(+8.5%) | $11.10 M(+3.2%) | $43.95 M(+3.5%) |
Sep 2022 | - | $10.76 M(-6.2%) | $42.44 M(+4.9%) |
Jun 2022 | - | $11.47 M(+8.1%) | $40.45 M(-8.2%) |
Mar 2022 | - | $10.62 M(+10.6%) | $44.08 M(+8.8%) |
Dec 2021 | $40.51 M | $9.60 M(+9.6%) | $40.51 M(+10.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2021 | - | $8.76 M(-42.0%) | $36.64 M(+12.1%) |
Jun 2021 | - | $15.10 M(+114.3%) | $32.67 M(+63.6%) |
Mar 2021 | - | $7.05 M(+23.0%) | $19.97 M(+30.2%) |
Dec 2020 | $15.34 M(+73.6%) | $5.73 M(+19.4%) | $15.34 M(+29.0%) |
Sep 2020 | - | $4.80 M(+100.5%) | $11.89 M(+21.5%) |
Jun 2020 | - | $2.39 M(-1.0%) | $9.79 M(+3.2%) |
Mar 2020 | - | $2.42 M(+6.2%) | $9.49 M(+7.3%) |
Dec 2019 | $8.84 M(+104.9%) | $2.28 M(-15.7%) | $8.84 M(+34.7%) |
Sep 2019 | - | $2.70 M(+29.0%) | $6.56 M(+69.9%) |
Jun 2019 | - | $2.09 M(+18.3%) | $3.86 M(+118.3%) |
Mar 2019 | - | $1.77 M | $1.77 M |
Dec 2018 | $4.31 M | - | - |
FAQ
- What is iTeos Therapeutics annual SGA?
- What is the all time high annual SGA for iTeos Therapeutics?
- What is iTeos Therapeutics annual SGA year-on-year change?
- What is iTeos Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for iTeos Therapeutics?
- What is iTeos Therapeutics quarterly SGA year-on-year change?
- What is iTeos Therapeutics TTM SGA?
- What is the all time high TTM SGA for iTeos Therapeutics?
- What is iTeos Therapeutics TTM SGA year-on-year change?
What is iTeos Therapeutics annual SGA?
The current annual SGA of ITOS is $50.40 M
What is the all time high annual SGA for iTeos Therapeutics?
iTeos Therapeutics all-time high annual SGA is $50.40 M
What is iTeos Therapeutics annual SGA year-on-year change?
Over the past year, ITOS annual SGA has changed by +$6.45 M (+14.67%)
What is iTeos Therapeutics quarterly SGA?
The current quarterly SGA of ITOS is $12.11 M
What is the all time high quarterly SGA for iTeos Therapeutics?
iTeos Therapeutics all-time high quarterly SGA is $15.10 M
What is iTeos Therapeutics quarterly SGA year-on-year change?
Over the past year, ITOS quarterly SGA has changed by -$257.00 K (-2.08%)
What is iTeos Therapeutics TTM SGA?
The current TTM SGA of ITOS is $324.27 M
What is the all time high TTM SGA for iTeos Therapeutics?
iTeos Therapeutics all-time high TTM SGA is $891.65 M
What is iTeos Therapeutics TTM SGA year-on-year change?
Over the past year, ITOS TTM SGA has changed by +$273.90 M (+543.74%)